Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical...

Prof Nicolas Girard - Institut Curie, Paris, France

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical benefit in patients with resectable NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Four chemo cycles given with durvalumab and tremelimumab optimise response and...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

LUMINANCE: Results support use of durvalumab and platinum-etoposide for...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for...

Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC ( Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA )

Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1...

Dr Margarita Majem Tarruella - Hospital de la Santa Creu i Sant Pau, Barcelona...

Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC ( Dr Margarita Majem Tarruella - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )

Assessment of QoL results and correlation with survival outcomes in phase III...

Dr Alberto Servetto - University of Naples Federico II, Naples, Italy

Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC ( Dr Alberto Servetto - University of Naples Federico II, Naples, Italy )

PSMO and the future of cancer care in the Philippines

Dr Rosario Pitargue - Philippine Society of Medical Oncology, Manila...

PSMO and the future of cancer care in the Philippines ( Dr Rosario Pitargue - Philippine Society of Medical Oncology, Manila, Philippines )

Low value practices that result in poor patient outcomes in LMICs

Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines

Low value practices that result in poor patient outcomes in LMICs ( Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines )

Key methods for handling difficult conversations in cancer care

Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila...

Key methods for handling difficult conversations in cancer care ( Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines )

Tumour markers and their role in cancer treatment

Dr Jasper Andal - St Luke's Medical Center, Manila, Philippines

Tumour markers and their role in cancer treatment ( Dr Jasper Andal - St Luke's Medical Center, Manila, Philippines )

Complementary and alternative medicine for cancer in the Philippines

Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital...

Complementary and alternative medicine for cancer in the Philippines ( Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines )

The Choosing Wisely Philippines project and its impact

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines

The Choosing Wisely Philippines project and its impact ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )

More from ecancer